Skip to main content
Equibles

MARSHALL WACE, LLP

Position in ZLAB — Zai Lab Ltd

CIK 1318757 LONDON, X0
Back to ZLAB Full portfolio

Position in ZLAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,797,123
-$1,291,863 QoQ
Shares Held
147,217
-36.5% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 92 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ZLAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. ZLAB ranks #127 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in ZLAB

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,797,123 147,217
2025-12-31 $4,088,986 231,802
2025-09-30 $2,080,912 61,402
2025-06-30 $855,225 24,456
2025-03-31 $1,009,426 27,931
2024-12-31 $7,568,700 288,992
2023-06-30 $412,040 14,859
2022-12-31 $267,397 8,710
2022-09-30 $297,882 8,710
2022-06-30 $2,056,765 59,307
2022-03-31 $383,065 8,710
2021-12-31 $27,662,107 440,129
2021-09-30 $26,313,880 249,681
2021-06-30 $638,048 3,605
2020-12-31 $9,015,944 66,617
2020-03-31 $73,101 1,420